Skip to Content
COVID-19 Response and Update
International
Amneal Pharmaceuticals
  • Corporate
  • India
  • About
        • AboutWe challenge convention so healthy can be possible
        • Our Story
          • Amneal at-a-glance
          • Our Founders
          • Our Milestones
        • Our Purpose & Commitments
        • Our Culture
          • Rise, Lead, Succeed
        • Our Leadership
          • Executive Leadership
          • Voices of Leadership
          • Board of Directors
        • Our Locations
        • Responsibility
          • The Amneal Patient Assistance Program
          • Product Donations
          • National and Local Philanthropy
          • Compliance and Ethics
        • Patient Community Connections
          • Our Commitment to Parkinson’s
        • Awards & Recognition
  • Products
        • ProductsWe create essential medicines
        • Our Portfolio
          • Biosciences
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
  • Research & Development
        • Research & DevelopmentWe invest significantly in new product development
        • Generics R&D
        • Specialty R&D
          • Drug Delivery Technologies
        • Product Partnering
  • Investors
        • InvestorsBecome an Informed Investor
        • Financial Reports
          • SEC Filings
          • Annual Reports
          • Quarterly & Other Reports
        • Events & Presentations
        • Stock Information
        • Corporate Governance
          • Policies
          • Executive Officers & Directors
          • Board Committees
        • Investor Resources
          • Analysts
          • Investor FAQ
          • Email Alerts
          • Information Request
          • RSS Feeds
  • News
  • Careers
        • CareersHelp make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
  • Contact
  • Customer Login

Our commitment to our communities

October 23, 2024

This September, Recovery Awareness month,  we launched the “Taking Control Over It” initiative to raise awareness, reduce stigma and educate the community about Amneal’s Naloxone HCl Nasal Spray and opioid emergencies. We are proud to partner with advocacy organizations such as  Mobilize Recovery, Young People In Recovery, and The Naloxone Project to donate product and resources to elevate the meaningful work they are doing. And we are proud to be playing a major sponsorship role in iHeart Media’s Mobilize Recovery Across America Bus Tour and their efforts in educate communities and raising awareness that recovery is possible.

Our Commitment

Since 2000, approximately 1 million people in the U.S. have died of drug overdoses, and that number unfortunately continues to grow. We are taking action. Here are some of our ongoing efforts:

  • Our Naloxone HCL Nasal Spray product is available without a prescription under the Amneal brand, and at select major U.S. pharmacies as the store private label product.
  • Our government relations team is partnering with government agencies to help drive increased access to this lifesaving opioid overdose reversal medicine.
  • We distributed Amneal Naloxone HCL Nasal Spray to all U.S. employees to help educate employees and reduce stigma.
  • We’re partnering with organizations including Mobilize Recovery, Young People In Recovery, and The Naloxone Project.

This is the reason Amneal exists, and we want to do all we can to make sure we get help to those who need it most.


 

See How We Touch People's Lives
  • Privacy Notice
  • Copyright & Legal Disclaimer
  • Web Accessibility
  • Expanded Access Policy
  • NABP DDA Accreditation
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
© 2025 Amneal Pharmaceuticals LLC.
All rights reserved.